DiBiase Mary — SEC Form 4 filings

SEC reporting owner CIK 1880179. 7 Form 4 filings on record with FilingPulse; latest filed 2025-02-14.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-02-12 to 2025-02-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
X4 Pharmaceuticals, Inc (XFOR)Chief Operating Officer75 legs · 111,687 sh · $67,4604

Form 4 filings — DiBiase Mary

FiledFormIssuerReported transactionsSource
2025-02-144X4 Pharmaceuticals, Inc (XFOR)Grant/award (A): 650,000 @ $0EDGAR
2025-01-274X4 Pharmaceuticals, Inc (XFOR)Grant/award (A): 61,178 @ $0 · Sale (S): 22,258 @ $0.45EDGAR
2024-10-084X4 Pharmaceuticals, Inc (XFOR)Grant/award (A): 230,645 @ $0 · Sale (S): 67,695 @ $0.57EDGAR
2024-09-114X4 Pharmaceuticals, Inc (XFOR)Sale (S): 2,642 @ $0.66EDGAR
2024-03-114X4 Pharmaceuticals, Inc (XFOR)Sale (S): 15,409 @ $0.88EDGAR
2024-02-164X4 Pharmaceuticals, Inc (XFOR)Grant/award (A): 428,248 (derivative) @ $0EDGAR
2024-02-124X4 Pharmaceuticals, Inc (XFOR)Sale (S): 3,683 @ $1.01EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1880179 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →